<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report the case of a 33-year-old female with known <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> who, despite full-dose oral anticoagulation, presented with <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo>, <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002098'>respiratory distress</z:hpo> syndrome, <z:e sem="disease" ids="C0264343" disease_type="Disease or Syndrome" abbrv="">purulent bronchitis</z:e>, and septic shock </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> and anti-beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi>-1 titres were markedly elevated </plain></SENT>
<SENT sid="2" pm="."><plain>The patient was diagnosed with catastrophic <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> and treated with unfractionated intravenous <z:chebi fb="5" ids="28304">heparin</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>However, she developed <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> of the right foot and skin marmoration of her extremities during <z:chebi fb="5" ids="28304">heparin</z:chebi> therapy, and therefore plasmapheresis, immunoglobulins, <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, and methylprednisone under a broad spectrum of anti-infective therapy were instituted </plain></SENT>
<SENT sid="4" pm="."><plain>This treatment led to a rapid decrease of <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> and anti-beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi>-1 titres, and the patient's condition gradually improved </plain></SENT>
<SENT sid="5" pm="."><plain>Upon discharge from the hospital, <z:hpo ids='HP_0002113'>pulmonary infiltrates</z:hpo> had markedly regressed, and she was feeling well </plain></SENT>
<SENT sid="6" pm="."><plain>Given the high mortality of catastrophic <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e>, this report emphasizes the need for rapid diagnosis and effective multimodal treatment in an intensive care unit setting for these patients </plain></SENT>
</text></document>